Tidemark’s Sanofi SNY Stock Holding History

Tidemark’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341	Hold	8	–	–	﹤0.01%	860
2026 Q1	$385	Hold	8	–	–	﹤0.01%	796
2025 Q4	$388	Hold	8	–	–	﹤0.01%	630
2025 Q3	$378	Hold	8	–	–	﹤0.01%	661
2025 Q2	$386	Hold	8	–	–	﹤0.01%	678
2025 Q1	$444	Buy	+8	New	+$433	﹤0.01%	677
2024 Q4	–	Sell	-8	Closed	-$461	–	675
2024 Q3	$461	Hold	8	–	–	﹤0.01%	599
2024 Q2	$388	Hold	8	–	–	﹤0.01%	597
2024 Q1	$389	Hold	8	–	–	﹤0.01%	668
2023 Q4	$398	Buy	+8	New	+$391	﹤0.01%	663

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Tidemark's SNY Position: Q2 2026 in Review

Tidemark held its Sanofi (SNY) position steady in Q2 2026 at 8 shares worth $341. The position accounts for ﹤0.01% of the portfolio, ranked #860.

Tidemark first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $461 in Q3 2024. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Tidemark held 8 shares of Sanofi worth $341 as of Q2 2026.
Tidemark left its Sanofi share count unchanged in Q2 2026.
Sanofi made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #860 holding.
Tidemark first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
Tidemark's Sanofi position peaked at $461 in Q3 2024.
714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.